CLOVER HEALTH INVESTMENTS, CORP. /DE
CLOVER HEALTH INVESTMENTS, CORP. /DE
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | - | - | - | - | - | - | - | 0 | 0 | 1 | 1 | 0 | |||||
Common Class A | - | 431 | 0 | 4 | 6 | 414 | 0 | 5 | 0 | 406 | 0 | 4 | |||||
Common Class B | - | 96 | 0 | 0 | -0 | 92 | 0 | -1 | 0 | 90 | 0 | 0 | |||||
Nonrelated Party | - | - | - | - | - | - | - | -0 | -0 | 1 | 1 | 0 | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value Includ… | 199 | 173 | 78 | 190 | 189 | 155 | 195 | 288 | 255 | 208 | 123 | 299 | |||||
Other Short Term Investments | 2 | 4 | 17 | - | - | - | 0 | 2 | 10 | 9 | 12 | 15 | |||||
Available For Sale Securities Debt Securities Curr… | 40 | 24 | 23 | 11 | 11 | 5 | 27 | 43 | 111 | 118 | 101 | 196 | |||||
Held To Maturity Securities Current | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 3 | 7 | 7 | 7 | |||||
Other Receivables | - | - | - | - | - | - | - | 15 | 21 | 23 | 17 | 15 | |||||
Receivables From Customers | 73 | 73 | 95 | 58 | 47 | 54 | 52 | 37 | 67 | 84 | 64 | 52 | |||||
Deposits Assets Current | - | - | - | - | - | - | - | 1 | 1 | 1 | 56 | 50 | |||||
Prepaid Expense Current | 19 | 18 | 18 | 12 | 15 | 17 | 13 | 13 | 15 | 17 | 14 | 15 | |||||
Other Assets Current | 20 | 23 | 11 | 12 | 15 | 16 | 16 | 3 | 4 | 5 | 19 | 1 | |||||
Assets Current | 485 | 448 | 308 | 331 | 363 | 331 | 343 | 433 | 550 | 553 | 428 | 916 | |||||
Assets Of Disposal Group Including Discontinued Op… | - | - | - | - | - | - | 0 | 10 | 10 | 11 | 72 | - | |||||
Available For Sale Securities Debt Securities Nonc… | 189 | 202 | 187 | 181 | 175 | 217 | 202 | 184 | 103 | 97 | 120 | 101 | |||||
Held To Maturity Securities Noncurrent | 10 | 12 | 13 | 12 | 13 | 14 | 14 | 14 | 1 | 1 | 1 | 1 | |||||
Property Plant And Equipment Net | 7 | 7 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | 3 | 3 | 3 | 3 | 4 | |||||
Intangible Assets Net Including Goodwill | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 19 | |||||
Other Assets Noncurrent | 25 | 25 | 24 | 27 | 16 | 14 | 13 | 11 | 10 | 10 | 14 | 15 | |||||
Assets | 720 | 698 | 541 | 560 | 575 | 584 | 581 | 653 | 674 | 672 | 571 | 685 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Assumed Liability For Unpaid Claims And Claims Adj… | 251 | 260 | 153 | 140 | 140 | 151 | 156 | 166 | 199 | 239 | 137 | 114 | |||||
Accounts Payable And Accrued Liabilities Current | 35 | 39 | 36 | 33 | 34 | 31 | 35 | 26 | 40 | 35 | 37 | 35 | |||||
Accrued Salaries Current And Noncurrent | 31 | 31 | 16 | 17 | 25 | 31 | 19 | 35 | 32 | 28 | 21 | 24 | |||||
Contract With Customer Liability Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 3 | 103 | |||||
Operating Lease Liability Current | - | - | - | - | - | - | - | 1 | 1 | 2 | 2 | 2 | |||||
Other Liabilities Current | 6 | 6 | 3 | 3 | 3 | 4 | 3 | - | - | - | 6 | - | |||||
Liabilities Current | 323 | 337 | 209 | 193 | 202 | 216 | 214 | 280 | 325 | 356 | 261 | 719 | |||||
Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | 2 | 3 | 3 | 3 | 3 | |||||
Liabilities Of Disposal Group Including Discontinu… | - | - | - | - | - | - | 0 | 49 | 49 | 51 | 60 | - | |||||
Other Liabilities Noncurrent | 21 | 22 | 23 | 25 | 29 | 32 | 26 | 29 | 22 | 20 | 23 | 16 | |||||
Liabilities | 344 | 358 | 232 | 219 | 231 | 248 | 240 | 311 | 349 | 379 | 284 | 738 | |||||
Equity | |||||||||||||||||
Additional Paid In Capital | 2,707 | 2,695 | 2,683 | 2,656 | 2,630 | 2,603 | 2,576 | 2,546 | 2,518 | 2,490 | 2,461 | 2,428 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -2 | -1 | 1 | 0 | 0 | -0 | -2 | 1 | -2 | -3 | -2 | -5 | |||||
Retained Earnings Accumulated Deficit | -2,233 | -2,261 | -2,288 | -2,239 | -2,215 | -2,204 | -2,203 | -2,181 | -2,172 | -2,179 | -2,160 | -2,089 | |||||
Treasury Stock Common Value | -96 | -94 | -86 | -77 | -71 | -63 | -31 | -24 | -19 | -16 | -13 | -12 | |||||
Stockholders Equity | 376 | 339 | 309 | 341 | 344 | 336 | 341 | 342 | 325 | 292 | 286 | 322 | |||||
Liability For Future Policy Benefits | - | - | - | - | - | - | - | - | - | - | 0 | 1 | |||||
Liabilities And Stockholders Equity | 720 | 698 | 541 | 560 | 575 | 584 | 581 | 653 | 674 | 672 | 571 | 1,060 | |||||
Debt Securities Available For Sale Amortized Cost … | 40 | 24 | 23 | 11 | 11 | 5 | 27 | 44 | 112 | 120 | 101 | 198 | |||||
Debt Securities Held To Maturity Fair Value Curren… | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 3 | 7 | 7 | 7 | |||||
Debt Securities Available For Sale Amortized Cost … | 191 | 203 | 186 | 180 | 175 | 217 | 203 | 183 | 104 | 98 | 122 | 105 | |||||
Debt Securities Held To Maturity Fair Value Noncur… | 10 | 12 | 12 | 12 | 12 | 14 | 14 | 14 | 1 | 1 | 1 | 1 | |||||
Treasury Stock Common Shares | 36 | 35 | - | 30 | 28 | 26 | 19 | 17 | 15 | 12 | 8 | 7 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 27.56% | 73.40% | 38.46% | - | - | - | - | - | - | - | - | - |
| 2025 | -10.54% | -21.37% | -13.53% | 20.18% | 46.79% | 75.23% | -6.74% | -5.99% | -3.00% | -9.57% | 4.78% | 66.03% |
| 2024 | 48.65% | 66.22% | 133.78% | 43.72% | 54.10% | 114.21% | 2.05% | -4.40% | 41.35% | -1.37% | -5.77% | -12.36% |
| 2023 | - | - | - | 0.00% | -18.80% | -31.43% | -15.93% | -15.75% | -15.04% | 0.28% | -4.14% | 51.72% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.50 | 1.33 | 1.47 | 1.71 | 1.80 | 1.54 | 1.61 | 1.55 | 1.69 | 1.55 | 1.64 | 1.27 | |||||
| Quick Ratio | 1.44 | 1.28 | 1.39 | 1.65 | 1.72 | 1.46 | 1.55 | 1.50 | 1.65 | 1.50 | 1.58 | 1.25 | |||||
| Working Capital | 162.12M | 111.44M | 99.03M | 137.47M | 160.99M | 115.76M | 129.61M | 153.09M | 225.07M | 196.35M | 166.86M | 197.00M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.91 | 1.06 | 0.75 | 0.64 | 0.67 | 0.74 | 0.70 | 0.91 | 1.08 | 1.30 | 0.99 | 2.29 | |||||
| Interest Coverage TTM | - | - | - | - | - | - | - | - | - | -21,190.57 | -29,332.71 | -1,745.03 | |||||
| Debt Ratio | 0.48 | 0.51 | 0.43 | 0.39 | 0.40 | 0.42 | 0.41 | 0.48 | 0.52 | 0.56 | 0.50 | 1.08 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 3.82 | 3.45 | 3.43 | 2.93 | 2.57 | 2.37 | 2.38 | 2.01 | 1.92 | 1.82 | 1.83 | 1.65 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.03 | -0.11 | -0.17 | -0.11 | -0.08 | -0.05 | -0.09 | -0.19 | -0.25 | -0.33 | -0.44 | -0.47 | |||||
| Free Cash Flow Per Share TTM | -0.09 | 0.10 | -0.13 | -0.14 | -0.06 | -0.02 | 0.07 | -0.28 | -0.43 | -0.41 | -0.30 | -0.38 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 18.57% | 18.39% | 18.50% | 21.18% | 23.86% | 26.37% | 26.61% | 24.77% | 24.41% | 41.60% | 39.68% | 72.35% | |||||
| Operating Profit Margin TTM | -0.74% | -2.57% | -4.44% | -3.25% | -2.62% | -1.64% | -3.34% | -6.49% | -8.49% | -11.54% | -16.29% | -13.51% | |||||
| Net Profit Margin TTM | -0.74% | -2.58% | -4.45% | -3.29% | -2.68% | -1.69% | -3.14% | -6.79% | -9.36% | -12.44% | -16.93% | -12.30% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 54.03% | 48.75% | 40.34% | 31.71% | 21.66% | 15.64% | 8.77% | -27.09% | -44.88% | -56.04% | -63.74% | -38.64% | |||||
| Net Income Growth (1Y) | -57.40% | 126.74% | 98.91% | -36.18% | -65.16% | -84.30% | -79.84% | -59.76% | -52.63% | -52.50% | -37.17% | -48.68% | |||||
| EPS Growth (1Y) | -58.63% | 115.83% | 90.38% | -38.99% | -66.63% | -84.63% | -80.16% | -60.53% | -53.44% | -53.24% | -37.94% | -49.01% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -149.59 | -16.14 | -14.06 | -26.90 | -32.95 | -71.06 | -35.89 | -15.13 | -4.85 | -2.41 | -2.15 | -2.29 | |||||
| P/B TTM | 7.30 | 2.71 | 3.90 | 4.60 | 4.13 | 5.31 | 4.52 | 4.04 | 1.85 | 1.32 | 1.60 | 1.61 | |||||
| P/S TTM | 1.11 | 0.42 | 0.63 | 0.88 | 0.88 | 1.20 | 1.13 | 1.03 | 0.45 | 0.30 | 0.36 | 0.28 | |||||
| Market Cap | 2.75B | 919.04M | 1.20B | 1.57B | 1.42B | 1.78B | 1.54B | 1.38B | 599.60M | 386.18M | 459.03M | 519.23M | |||||
| Enterprise Value | 2.55B | 745.78M | 1.12B | 1.38B | 1.23B | 1.63B | 1.35B | 1.09B | 344.83M | 177.93M | 282.54M | 167.49M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -49.65M | 54.54M | -68.98M | -69.90M | -31.72M | -8.68M | 33.29M | -138.91M | -207.52M | -199.07M | -145.77M | -183.09M | |||||
| Net Debt | -198.84M | -173.27M | -78.30M | -190.06M | -188.65M | -155.44M | -194.54M | -287.96M | -254.77M | -208.26M | -176.49M | -351.74M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) — SEC Financial Statements & Analysis
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) is a hospital & medical service plans company, incorporated in DE. CLOVER HEALTH INVESTMENTS, CORP. /DE trades on Nasdaq as: CLOV. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CLOVER HEALTH INVESTMENTS, CORP. /DE reported a 54.03% year-over-year revenue growth, a Gross Profit Margin of 18.57% (TTM), a Debt-to-Equity ratio of 0.91x, a Price-to-Sales (P/S) ratio of 1.11x (TTM), a Price-to-Book (P/B) ratio of 7.30x (TTM), at a market cap of $2.75B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 54.03%
- Gross Profit Margin TTM
- 18.57%
- Debt To Equity
- 0.91x
- P/S TTM
- 1.11x
- P/B TTM
- 7.30x
- Market Cap
- $2.75B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CLOVER HEALTH INVESTMENTS, CORP. /DE in?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) operates in the Hospital & Medical Service Plans industry.
What is CLOV's market cap?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) has a market capitalization of $2.75B as of 2026-06-30.
What exchange does CLOV trade on?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) trades on the Nasdaq.
Where is CLOVER HEALTH INVESTMENTS, CORP. /DE incorporated?
CLOVER HEALTH INVESTMENTS, CORP. /DE is incorporated in DE.